AU2020901800A0 - Therapeutic methods and agents - Google Patents

Therapeutic methods and agents

Info

Publication number
AU2020901800A0
AU2020901800A0 AU2020901800A AU2020901800A AU2020901800A0 AU 2020901800 A0 AU2020901800 A0 AU 2020901800A0 AU 2020901800 A AU2020901800 A AU 2020901800A AU 2020901800 A AU2020901800 A AU 2020901800A AU 2020901800 A0 AU2020901800 A0 AU 2020901800A0
Authority
AU
Australia
Prior art keywords
agents
therapeutic methods
therapeutic
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020901800A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Implicit Bioscience Ltd
Original Assignee
Implicit Bioscience Ltd
Filing date
Publication date
Application filed by Implicit Bioscience Ltd filed Critical Implicit Bioscience Ltd
Publication of AU2020901800A0 publication Critical patent/AU2020901800A0/en
Priority to PCT/AU2021/050292 priority Critical patent/WO2021243396A1/en
Pending legal-status Critical Current

Links

AU2020901800A 2020-06-01 2020-06-01 Therapeutic methods and agents Pending AU2020901800A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2021/050292 WO2021243396A1 (en) 2020-06-01 2021-03-31 Therapeutic methods of using cd 14 antagonistic antibodies in treating conditions associated with a coronavirus infection including sars-cov-2 (covid-19)

Publications (1)

Publication Number Publication Date
AU2020901800A0 true AU2020901800A0 (en) 2020-06-18

Family

ID=

Similar Documents

Publication Publication Date Title
EP3920923A4 (en) Therapeutic agents and methods of treatment
EP4003401A4 (en) Compositions and methods comprising protease-activated therapeutic agents
EP3870203A4 (en) Therapeutic combinations of tdfrps and additional agents and methods of use
EP4037715A4 (en) Protein-macromolecule conjugates and methods of use thereof
EP3972647A4 (en) Drug conjugates and methods of using same
EP4090752A4 (en) Plakophillin-2 gene therapy methods and compositions
EP3960766A4 (en) Tumor therapeutic agent and use thereof
EP4013319A4 (en) Cellulite treatment system and methods
EP4013445A4 (en) Therapeutic protein compositions and methods
EP4017493A4 (en) Methods of treatment using bcn057 and bcn512
EP3983059A4 (en) Ear device and paired treatments involving nerve stimulation
EP3787639A4 (en) Therapeutic uses and methods
EP3999092A4 (en) Combination cancer therapy agents and methods
AU2020901854A0 (en) Therapeutic methods and agents
AU2020901800A0 (en) Therapeutic methods and agents
EP4013401A4 (en) Articles and methods for administration of therapeutic agents
EP3960242A4 (en) Conjugate and cancer therapeutic agent
AU2021901067A0 (en) Therapeutic agents and uses therefor
AU2020901994A0 (en) Therapeutic agents and uses therefor
EP3919472A4 (en) Dezocine derivative and medical use thereof
EP4017589A4 (en) Therapeutic methods and uses thereof
AU2019901540A0 (en) Therapeutic uses and methods
AU2019903095A0 (en) Therapeutic Methods And Uses Thereof
AU2021903239A0 (en) Agents and methods for therapy and prophylaxis
AU2021900345A0 (en) Agents and methods for therapy and prophylaxis